CL2-38093-009 - Safety and efficacy of S 38093 and donepezil, during 4 weeks, in patients with mild to moderate Azheimer’s Disease. An international, multi-centre, randomised, double-blind, placebo-controlled, phase II add-on study

External Coordinator or non-active

Prof.Luís Cunha

Start

June 2006

Centres and/or Units

CEB - Centre for Bioavailability Studies

Research area

Clinical Trial

Projects by department: